11:48 pm, Monday, 20 October 2025
TOP NEWS

From Classified Ads to Criminal Charges: Backpage Founder Sentenced

Backpage.com, once a major online classified advertising platform, gained notoriety for its controversial “Adult Services” section, which became a hub

Hidden Cameras, Hidden Crimes: Upskirting Scandal Unveiled at British Museum

A man caught upskirting at the British Museum has been sentenced to four months in jail. Jake Verano Gomez, a

China’s Beauty Clone Epidemic: 500 Followers Undergo Surgery to Look Like This Influencer

A popular Chinese beauty influencer, Wang Jing, has inspired over 500 of her followers to replicate her youthful appearance through

Unveiling the World’s Rarest Snakes: A Glimpse into Nature’s Hidden Wonders

Snakes have long been enveloped in mystery, often feared due to widespread misconceptions. Despite their ominous reputation, these reptiles are

Why Wearing Goggles is Crucial for Eye Safety When Swimming

Swimming can be an exhilarating experience, but when it comes to eye safety, it’s time to reconsider the habit of

Staying Focused Amidst the Chaos: Strategies to be Like a Bangladeshi Olympian!

In today’s fast-paced world, maintaining focus can feel like an uphill battle, especially when distractions seem constant and unavoidable. Whether

Effective Strategies to Control Dandruff: Prevent Hair Loss and Maintain Scalp Health

Dandruff is a common issue that affects not only the scalp but can also appear on the face, ears, lips,

AI’s Dark Side: New Warnings About Its Potential to Create Deadly Viruses

As AI technology advances, specialized models designed to handle biological data are making significant strides. These models have the potential

Australia’s Harsh Crackdown: International Students Face Visa Caps Amid Record Migration Surge!

Australia is tightening its grip on international student visas, capping new enrollments at 270,000 in 2025—a dramatic reduction from the

Mpox Outbreak Worsens as Antiviral Tecovirimat Fails in DRC Trials

The ongoing mpox outbreak in Central Africa has taken a troubling turn as a promising antiviral treatment, tecovirimat (TPOXX), has